Diabetes   

Some oncologists may have concerns that checkpoint inhibitors could diminish islet cell reserve and lead to worsening DM control.

Do you avoid using these agents only in patients with history of medullary thyroid cancer or pancreatic cancer? Are there other cancer risks we should...